IBDEI0DK ; ; 09-MAY-2014
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;MAY 09, 2014
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,18322,0)
 ;;=V17.7^^110^1112^3
 ;;^UTILITY(U,$J,358.3,18322,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,18322,1,4,0)
 ;;=4^V17.7
 ;;^UTILITY(U,$J,358.3,18322,1,5,0)
 ;;=5^Family H/O Arthritis
 ;;^UTILITY(U,$J,358.3,18322,2)
 ;;=^295309
 ;;^UTILITY(U,$J,358.3,18323,0)
 ;;=V19.0^^110^1112^5
 ;;^UTILITY(U,$J,358.3,18323,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,18323,1,4,0)
 ;;=4^V19.0
 ;;^UTILITY(U,$J,358.3,18323,1,5,0)
 ;;=5^Family H/O Blindness
 ;;^UTILITY(U,$J,358.3,18323,2)
 ;;=^295320
 ;;^UTILITY(U,$J,358.3,18324,0)
 ;;=V16.3^^110^1112^6
 ;;^UTILITY(U,$J,358.3,18324,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,18324,1,4,0)
 ;;=4^V16.3
 ;;^UTILITY(U,$J,358.3,18324,1,5,0)
 ;;=5^Family H/O Cancer Of Breast
 ;;^UTILITY(U,$J,358.3,18324,2)
 ;;=^295295
 ;;^UTILITY(U,$J,358.3,18325,0)
 ;;=V16.41^^110^1112^9
 ;;^UTILITY(U,$J,358.3,18325,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,18325,1,4,0)
 ;;=4^V16.41
 ;;^UTILITY(U,$J,358.3,18325,1,5,0)
 ;;=5^Family H/O Cancer Of Ovary
 ;;^UTILITY(U,$J,358.3,18325,2)
 ;;=^317951
 ;;^UTILITY(U,$J,358.3,18326,0)
 ;;=V16.42^^110^1112^10
 ;;^UTILITY(U,$J,358.3,18326,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,18326,1,4,0)
 ;;=4^V16.42
 ;;^UTILITY(U,$J,358.3,18326,1,5,0)
 ;;=5^Family H/O Cancer Of Prostate
 ;;^UTILITY(U,$J,358.3,18326,2)
 ;;=^317952
 ;;^UTILITY(U,$J,358.3,18327,0)
 ;;=V16.43^^110^1112^11
 ;;^UTILITY(U,$J,358.3,18327,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,18327,1,4,0)
 ;;=4^V16.43
 ;;^UTILITY(U,$J,358.3,18327,1,5,0)
 ;;=5^Family H/O Cancer Of Testis
 ;;^UTILITY(U,$J,358.3,18327,2)
 ;;=^317953
 ;;^UTILITY(U,$J,358.3,18328,0)
 ;;=V19.5^^110^1112^12
 ;;^UTILITY(U,$J,358.3,18328,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,18328,1,4,0)
 ;;=4^V19.5
 ;;^UTILITY(U,$J,358.3,18328,1,5,0)
 ;;=5^Family H/O Congenital Anomalies
 ;;^UTILITY(U,$J,358.3,18328,2)
 ;;=^295325
 ;;^UTILITY(U,$J,358.3,18329,0)
 ;;=V19.2^^110^1112^13
 ;;^UTILITY(U,$J,358.3,18329,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,18329,1,4,0)
 ;;=4^V19.2
 ;;^UTILITY(U,$J,358.3,18329,1,5,0)
 ;;=5^Family H/O Deafness Or Hearing Loss
 ;;^UTILITY(U,$J,358.3,18329,2)
 ;;=^295322
 ;;^UTILITY(U,$J,358.3,18330,0)
 ;;=V17.3^^110^1112^15
 ;;^UTILITY(U,$J,358.3,18330,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,18330,1,4,0)
 ;;=4^V17.3
 ;;^UTILITY(U,$J,358.3,18330,1,5,0)
 ;;=5^Family H/O Ischemic Heart Dis
 ;;^UTILITY(U,$J,358.3,18330,2)
 ;;=^295305
 ;;^UTILITY(U,$J,358.3,18331,0)
 ;;=V16.6^^110^1112^16
 ;;^UTILITY(U,$J,358.3,18331,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,18331,1,4,0)
 ;;=4^V16.6
 ;;^UTILITY(U,$J,358.3,18331,1,5,0)
 ;;=5^Family H/O Leukemia
 ;;^UTILITY(U,$J,358.3,18331,2)
 ;;=^295298
 ;;^UTILITY(U,$J,358.3,18332,0)
 ;;=V18.61^^110^1112^19
 ;;^UTILITY(U,$J,358.3,18332,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,18332,1,4,0)
 ;;=4^V18.61
 ;;^UTILITY(U,$J,358.3,18332,1,5,0)
 ;;=5^Family H/O Polycystic Kidney
 ;;^UTILITY(U,$J,358.3,18332,2)
 ;;=^321531
 ;;^UTILITY(U,$J,358.3,18333,0)
 ;;=V17.0^^110^1112^20
 ;;^UTILITY(U,$J,358.3,18333,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,18333,1,4,0)
 ;;=4^V17.0
 ;;^UTILITY(U,$J,358.3,18333,1,5,0)
 ;;=5^Family H/O Psychiatric Condition
 ;;^UTILITY(U,$J,358.3,18333,2)
 ;;=^295302
 ;;^UTILITY(U,$J,358.3,18334,0)
 ;;=V19.4^^110^1112^21
 ;;^UTILITY(U,$J,358.3,18334,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,18334,1,4,0)
 ;;=4^V19.4
 ;;^UTILITY(U,$J,358.3,18334,1,5,0)
 ;;=5^Family H/O Skin Condition
 ;;^UTILITY(U,$J,358.3,18334,2)
 ;;=^295324
 ;;^UTILITY(U,$J,358.3,18335,0)
 ;;=V17.1^^110^1112^22
 ;;^UTILITY(U,$J,358.3,18335,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,18335,1,4,0)
 ;;=4^V17.1
 ;;^UTILITY(U,$J,358.3,18335,1,5,0)
 ;;=5^Family H/O Stroke (Cerebrovascular)
 ;;^UTILITY(U,$J,358.3,18335,2)
 ;;=^295303
 ;;^UTILITY(U,$J,358.3,18336,0)
 ;;=V16.8^^110^1112^18
 ;;^UTILITY(U,$J,358.3,18336,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,18336,1,4,0)
 ;;=4^V16.8
 ;;^UTILITY(U,$J,358.3,18336,1,5,0)
 ;;=5^Family H/O Other Specified Cancer
 ;;^UTILITY(U,$J,358.3,18336,2)
 ;;=^295300
 ;;^UTILITY(U,$J,358.3,18337,0)
 ;;=V11.1^^110^1112^23
 ;;^UTILITY(U,$J,358.3,18337,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,18337,1,4,0)
 ;;=4^V11.1
 ;;^UTILITY(U,$J,358.3,18337,1,5,0)
 ;;=5^Hx Of Affective Disorder
 ;;^UTILITY(U,$J,358.3,18337,2)
 ;;=^295250
 ;;^UTILITY(U,$J,358.3,18338,0)
 ;;=V15.89^^110^1112^46
 ;;^UTILITY(U,$J,358.3,18338,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,18338,1,4,0)
 ;;=4^V15.89
 ;;^UTILITY(U,$J,358.3,18338,1,5,0)
 ;;=5^Hx Of Persian Gulf Region Exposure
 ;;^UTILITY(U,$J,358.3,18338,2)
 ;;=^295291
 ;;^UTILITY(U,$J,358.3,18339,0)
 ;;=V11.3^^110^1112^24
 ;;^UTILITY(U,$J,358.3,18339,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,18339,1,4,0)
 ;;=4^V11.3
 ;;^UTILITY(U,$J,358.3,18339,1,5,0)
 ;;=5^Hx Of Alcoholism
 ;;^UTILITY(U,$J,358.3,18339,2)
 ;;=^295252
 ;;^UTILITY(U,$J,358.3,18340,0)
 ;;=V15.07^^110^1112^35
 ;;^UTILITY(U,$J,358.3,18340,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,18340,1,4,0)
 ;;=4^V15.07
 ;;^UTILITY(U,$J,358.3,18340,1,5,0)
 ;;=5^Hx Of Latex Allergy
 ;;^UTILITY(U,$J,358.3,18340,2)
 ;;=^322043
 ;;^UTILITY(U,$J,358.3,18341,0)
 ;;=V13.4^^110^1112^25
 ;;^UTILITY(U,$J,358.3,18341,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,18341,1,4,0)
 ;;=4^V13.4
 ;;^UTILITY(U,$J,358.3,18341,1,5,0)
 ;;=5^Hx Of Arthritis
 ;;^UTILITY(U,$J,358.3,18341,2)
 ;;=^295267
 ;;^UTILITY(U,$J,358.3,18342,0)
 ;;=V12.72^^110^1112^27
 ;;^UTILITY(U,$J,358.3,18342,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,18342,1,4,0)
 ;;=4^V12.72
 ;;^UTILITY(U,$J,358.3,18342,1,5,0)
 ;;=5^Hx Of Colon Polyps
 ;;^UTILITY(U,$J,358.3,18342,2)
 ;;=^303401
 ;;^UTILITY(U,$J,358.3,18343,0)
 ;;=V12.59^^110^1112^28
 ;;^UTILITY(U,$J,358.3,18343,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,18343,1,4,0)
 ;;=4^V12.59
 ;;^UTILITY(U,$J,358.3,18343,1,5,0)
 ;;=5^Hx Of Congestive Heart Failure
 ;;^UTILITY(U,$J,358.3,18343,2)
 ;;=^303399
 ;;^UTILITY(U,$J,358.3,18344,0)
 ;;=V45.81^^110^1112^29
 ;;^UTILITY(U,$J,358.3,18344,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,18344,1,4,0)
 ;;=4^V45.81
 ;;^UTILITY(U,$J,358.3,18344,1,5,0)
 ;;=5^Hx Of Coronary Bypass
 ;;^UTILITY(U,$J,358.3,18344,2)
 ;;=^97129
 ;;^UTILITY(U,$J,358.3,18345,0)
 ;;=V15.84^^110^1112^26
 ;;^UTILITY(U,$J,358.3,18345,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,18345,1,4,0)
 ;;=4^V15.84
 ;;^UTILITY(U,$J,358.3,18345,1,5,0)
 ;;=5^Hx Of Asbestos Exposure
 ;;^UTILITY(U,$J,358.3,18345,2)
 ;;=^303406
 ;;^UTILITY(U,$J,358.3,18346,0)
 ;;=V15.85^^110^1112^47
 ;;^UTILITY(U,$J,358.3,18346,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,18346,1,4,0)
 ;;=4^V15.85
 ;;^UTILITY(U,$J,358.3,18346,1,5,0)
 ;;=5^Hx Of Potentially Hazardous Body Fluids
 ;;^UTILITY(U,$J,358.3,18346,2)
 ;;=^303407
 ;;^UTILITY(U,$J,358.3,18347,0)
 ;;=V10.72^^110^1112^32
 ;;^UTILITY(U,$J,358.3,18347,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,18347,1,4,0)
 ;;=4^V10.72
 ;;^UTILITY(U,$J,358.3,18347,1,5,0)
 ;;=5^Hx Of Hodgkin's Disease
 ;;^UTILITY(U,$J,358.3,18347,2)
 ;;=^295237
 ;;^UTILITY(U,$J,358.3,18348,0)
 ;;=V15.3^^110^1112^33
 ;;^UTILITY(U,$J,358.3,18348,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,18348,1,4,0)
 ;;=4^V15.3
 ;;^UTILITY(U,$J,358.3,18348,1,5,0)
 ;;=5^Hx Of Irradiation
 ;;^UTILITY(U,$J,358.3,18348,2)
 ;;=^295285
 ;;^UTILITY(U,$J,358.3,18349,0)
 ;;=V10.61^^110^1112^36
 ;;^UTILITY(U,$J,358.3,18349,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,18349,1,4,0)
 ;;=4^V10.61
 ;;^UTILITY(U,$J,358.3,18349,1,5,0)
 ;;=5^Hx Of Lymphoid Leukemia
 ;;^UTILITY(U,$J,358.3,18349,2)
 ;;=Hx of Lymphoid Leukemia^295232
 ;;^UTILITY(U,$J,358.3,18350,0)
 ;;=V12.03^^110^1112^38
 ;;^UTILITY(U,$J,358.3,18350,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,18350,1,4,0)
 ;;=4^V12.03
 ;;^UTILITY(U,$J,358.3,18350,1,5,0)
 ;;=5^Hx Of Malaria
 ;;^UTILITY(U,$J,358.3,18350,2)
 ;;=Hx of Malaria^303395
 ;;^UTILITY(U,$J,358.3,18351,0)
 ;;=V10.82^^110^1112^39
 ;;^UTILITY(U,$J,358.3,18351,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,18351,1,4,0)
 ;;=4^V10.82
 ;;^UTILITY(U,$J,358.3,18351,1,5,0)
 ;;=5^Hx Of Malignant Melanoma
 ;;^UTILITY(U,$J,358.3,18351,2)
 ;;=Hx of Malignant Melanoma^295240
 ;;^UTILITY(U,$J,358.3,18352,0)
 ;;=V10.62^^110^1112^42
 ;;^UTILITY(U,$J,358.3,18352,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,18352,1,4,0)
 ;;=4^V10.62
 ;;^UTILITY(U,$J,358.3,18352,1,5,0)
 ;;=5^Hx Of Myeloid Leukemia
 ;;^UTILITY(U,$J,358.3,18352,2)
 ;;=Hx of Myeloid Leukemia^295233
 ;;^UTILITY(U,$J,358.3,18353,0)
 ;;=V10.63^^110^1112^40
 ;;^UTILITY(U,$J,358.3,18353,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,18353,1,4,0)
 ;;=4^V10.63
 ;;^UTILITY(U,$J,358.3,18353,1,5,0)
 ;;=5^Hx Of Monocytic Leukemia
 ;;^UTILITY(U,$J,358.3,18353,2)
 ;;=Hx of Monocytic Leukemia^295234
 ;;^UTILITY(U,$J,358.3,18354,0)
 ;;=V11.2^^110^1112^30
 ;;^UTILITY(U,$J,358.3,18354,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,18354,1,4,0)
 ;;=4^V11.2
 ;;^UTILITY(U,$J,358.3,18354,1,5,0)
 ;;=5^Hx Of Dysthymia
 ;;^UTILITY(U,$J,358.3,18354,2)
 ;;=Hx of Dysthymia^295251
 ;;^UTILITY(U,$J,358.3,18355,0)
 ;;=V15.81^^110^1112^60
 ;;^UTILITY(U,$J,358.3,18355,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,18355,1,4,0)
 ;;=4^V15.81
 ;;^UTILITY(U,$J,358.3,18355,1,5,0)
 ;;=5^Noncompliance With Medical Treatment
 ;;^UTILITY(U,$J,358.3,18355,2)
 ;;=^295290
 ;;^UTILITY(U,$J,358.3,18356,0)
 ;;=V10.43^^110^1112^43
 ;;^UTILITY(U,$J,358.3,18356,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,18356,1,4,0)
 ;;=4^V10.43
 ;;^UTILITY(U,$J,358.3,18356,1,5,0)
 ;;=5^Hx Of Ovarian Ca
 ;;^UTILITY(U,$J,358.3,18356,2)
 ;;=Hx of Ovarian CA^295221
 ;;^UTILITY(U,$J,358.3,18357,0)
 ;;=V12.71^^110^1112^45
 ;;^UTILITY(U,$J,358.3,18357,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,18357,1,4,0)
 ;;=4^V12.71
 ;;^UTILITY(U,$J,358.3,18357,1,5,0)
 ;;=5^Hx Of Peptic Ulcer Disease
 ;;^UTILITY(U,$J,358.3,18357,2)
 ;;=^303400
 ;;^UTILITY(U,$J,358.3,18358,0)
 ;;=V10.46^^110^1112^48
